Gautam Sajeev
Overview
Explore the profile of Gautam Sajeev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu T, Fillbrunn M, Zhang S, Chen J, Li W, Platt J, et al.
Ann Hematol
. 2025 Mar;
PMID: 40069437
Anemia affects many patients with myelofibrosis and is associated with poor prognosis. The Janus kinase inhibitor ruxolitinib is often used in myelofibrosis but may cause or worsen anemia. Using healthcare...
2.
Masarova L, Liu T, Fillbrunn M, Li W, Sajeev G, Rao S, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682253
Red blood cell transfusions for anemia impose high financial and healthcare resource utilization burdens on patients with myelofibrosis (MF). This study estimates projected differences in medical costs and transfusion-related cost...
3.
Masarova L, Verstovsek S, Liu T, Rao S, Sajeev G, Fillbrunn M, et al.
Future Oncol
. 2024 Jul;
20(30):2259-2270.
PMID: 39072442
To estimate projected US-based cost and time burden for patients with myelofibrosis and anemia treated with momelotinib compared with danazol. Cost and time burden were calculated based on the transfusion...
4.
Muntoni F, Signorovitch J, Sajeev G, Done N, Yao Z, Goemans N, et al.
PLoS One
. 2024 Jul;
19(7):e0304984.
PMID: 38985784
Evaluations of treatment efficacy in Duchenne muscular dystrophy (DMD), a rare genetic disease that results in progressive muscle wasting, require an understanding of the 'meaningfulness' of changes in functional measures....
5.
McDonald C, Signorovitch J, Mercuri E, Niks E, Wong B, Fillbrunn M, et al.
PLoS One
. 2024 Jun;
19(6):e0304099.
PMID: 38829874
This study examined functional trajectories of subjects during the transition phase between ambulatory and non-ambulatory Duchenne muscular dystrophy (DMD) to inform clinical trial designs for new therapeutics. Ambulatory, pulmonary, and...
6.
Kokaliaris C, Evans R, Hawkins N, Mahajan A, Scott D, Sutherland C, et al.
Adv Ther
. 2024 May;
41(6):2414-2434.
PMID: 38705943
Introduction: Spinal muscular atrophy (SMA) is a severe genetic neuromuscular disease characterized by a loss of motor neurons and progressive muscle weakness. Children with untreated type 1 SMA never sit...
7.
Yarur A, Mantzaris G, Wang S, Adsul S, Kamble P, Cook E, et al.
Adv Ther
. 2024 Apr;
41(6):2324-2341.
PMID: 38658485
Introduction: This analysis evaluated the relative performance of vedolizumab and anti-tumor necrosis factor alpha (anti-TNFα) agents in subpopulations of biologic therapy-naive patients with Crohn's disease (CD) and assessed whether patients...
8.
van de Velde N, Koeks Z, Signorelli M, Verwey N, Overzier M, Bakker J, et al.
Neurology
. 2023 Feb;
100(9):e975-e984.
PMID: 36849458
Background And Objectives: The slow and variable disease progression of Becker muscular dystrophy (BMD) urges the development of biomarkers to facilitate clinical trials. We explored changes in 3 muscle-enriched biomarkers...
9.
Muntoni F, Signorovitch J, Sajeev G, Lane H, Jenkins M, Dieye I, et al.
Neurology
. 2023 Feb;
100(15):e1540-e1554.
PMID: 36725339
Background And Objectives: Clinical trials of genotype-targeted treatments in Duchenne muscular dystrophy (DMD) traditionally compare treated patients with untreated patients with the same genotype class. This avoids confounding of drug...
10.
Lin C, Sajeev G, Stiff P, Brunstein C, Cutler C, Sanz G, et al.
Transplant Cell Ther
. 2022 Sep;
29(1):52.e1-52.e9.
PMID: 36179986
Omidubicel is an advanced cell therapy derived from umbilical cord blood (UCB) for use in allogeneic hematopoietic cell transplantation (HCT). A recent randomized phase 3 clinical trial demonstrated faster engraftment,...